ADCYAP1 and type 2 diabetes mellitus: Our previously generated PACAP-Tg mice show ameliorated streptozotocin-induced type 1 diabetes [12], normalized hyperplasia of pancreatic islets, and attenuated hyperinsulinemia in mouse models of type 2 diabetes [3], [4], [13], [14].